Björn Dahlbäck
1 – 50 of 274
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Natural anticoagulant discovery, the gift that keeps on giving : finding FV-Short
(
- Contribution to journal › Scientific review
- 2022
-
Mark
A hydrophobic patch (PLVIVG; 1481–1486) in the B-domain of factor V-short is crucial for its synergistic TFPIα-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIα, and protein S
(
- Contribution to journal › Article
-
Mark
Diagnosis and management of severe congenital protein C deficiency (SCPCD) : Communication from the SSC of the ISTH
(
- Contribution to journal › Article
-
Mark
Classic Thrombophilias and Thrombotic Risk Among Middle-Aged and Older Adults : A Population-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
The preAR2 region (1458–1492) in factor V-Short is crucial for the synergistic TFPIα-cofactor activity with protein S and the assembly of a trimolecular factor Xa-inhibitory complex comprising FV-Short, protein S, and TFPIα
(
- Contribution to journal › Article
- 2021
-
Mark
Pleiotropic anticoagulant functions of protein S, consequences for the clinical laboratory. Communication from the SSC of the ISTH
(
- Contribution to journal › Article
- 2020
-
Mark
Reduced Apolipoprotein M and Adverse Outcomes across the Spectrum of Human Heart Failure
(
- Contribution to journal › Article
-
Mark
Advances in understanding mechanisms of thrombophilic disorders
(
- Contribution to journal › Scientific review
-
Mark
Genetic risk factors for venous thromboembolism
(
- Contribution to journal › Scientific review
- 2019
-
Mark
New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short
(
- Contribution to journal › Article
-
Mark
Plasma Apolipoprotein M and Sphingosine-1-Phosphate Levels are Inversely Associated with Mortality in African Americans with Type 2 Diabetes Mellitus
(
- Contribution to journal › Article
-
Mark
Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2018
-
Mark
Lean ApoM−/− Mice with Hyperactive Brown Adipose Tissue
(
- Contribution to journal › Article
-
Mark
Treating hemophilia by targeting protein S?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate
(
- Contribution to journal › Article
-
Mark
Evaluation of Expression Level of Apolipoprotein M as a Diagnostic Marker for Primary Venous Thromboembolism
(
- Contribution to journal › Article
-
Mark
Vitamin K–Dependent Protein S : Beyond the Protein C Pathway
(
- Contribution to journal › Article
- 2017
-
Mark
HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium
(
- Contribution to journal › Article
-
Mark
Implications of cerebrovascular ATP-binding cassette transporter G1 (ABCG1) and apolipoprotein M in cholesterol transport at the blood-brain barrier
(
- Contribution to journal › Article
-
Mark
High-Density Lipoprotein–Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1
(
- Contribution to journal › Article
-
Mark
Factor V-short and protein S as synergistic tissue factor pathway inhibitor (TFPIα) cofactors
(
- Contribution to journal › Article
-
Mark
Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S
(
- Contribution to journal › Article
-
Mark
The nanoparticle protein corona formed in human blood or human blood fractions
(
- Contribution to journal › Article
-
Mark
Gas6-Axl signaling in presence of Sunitinib is enhanced, diversified and sustained in renal tumor cells, resulting in tumor-progressive advantages
(
- Contribution to journal › Article
-
Mark
Diminished airway macrophage expression of the Axl receptor tyrosine kinase is associated with defective efferocytosis in asthma
(
- Contribution to journal › Letter
-
Mark
A Shift in ApoM/S1P between HDL-Particles in Women with Type 1 Diabetes Mellitus Is Associated with Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex
(
- Contribution to journal › Article
- 2016
-
Mark
Urinary apolipoprotein M as a biomarker of acute kidney injury in children undergoing heart surgery.
(
- Contribution to journal › Article
-
Mark
Gas6 fueling tumor-mediated thrombosis.
(
- Contribution to journal › Article
-
Mark
Epidemiology of Familial Aggregation of Venous Thromboembolism
(
- Contribution to journal › Scientific review
-
Mark
Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism
(
- Contribution to journal › Article
-
Mark
Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons
(
- Contribution to journal › Article
-
Mark
Familial hypercholesterolaemia : cholesterol efflux and coronary disease
(
- Contribution to journal › Article
-
Mark
Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders
(
- Contribution to journal › Article
-
Mark
The Gas6-Axl Interaction Mediates Endothelial Uptake of Platelet Microparticles
(
- Contribution to journal › Article
- 2015
-
Mark
The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.
(
- Contribution to journal › Article
-
Mark
Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.
(
- Contribution to journal › Article
-
Mark
Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation.
(
- Contribution to journal › Article
-
Mark
HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation.
(
- Contribution to journal › Article
-
Mark
Protein Unfolding allow use of Commercial Antibodies in an Apolipoprotein M sandwich ELISA.
(
- Contribution to journal › Article
- 2014
-
Mark
Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.
(
- Contribution to journal › Article
-
Mark
The association between apolipoprotein M and insulin resistance varies with country of birth.
(
- Contribution to journal › Article
-
Mark
The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M and the risk of unprovoked recurrent venous thromboembolism.
(
- Contribution to journal › Article
-
Mark
Size-Dependent Effects of Nanoparticles on Enzymes in the Blood Coagulation Cascade.
(
- Contribution to journal › Article
-
Mark
TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain
(
- Contribution to journal › Article
-
Mark
Targeting exosites of activated protein C as therapeutic possibility?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.
(
- Contribution to journal › Article
- 2013
-
Mark
Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation
(
- Contribution to journal › Article
-
Mark
Coagulation factor V-A2440G causes east Texas bleeding disorder via TFPI alpha
(
- Contribution to journal › Article
- 2012
-
Mark
Small and large PROS1 deletions but no other types of rearrangements detected in patents with protein S deficiency
(
- Contribution to journal › Article